Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats

被引:113
|
作者
Marco, EM
Pérez-Alvarez, L
Borcel, E
Rubio, M
Guaza, C
Ambrosio, E
File, SE
Viveros, MP
机构
[1] Univ Complutense, Fac Biol, Dept Fisiol Anim 2, E-28040 Madrid, Spain
[2] CSIC, Inst Cajal, E-28002 Madrid, Spain
[3] Univ Nacl Educ Distancia, Dept Psicobiol, Madrid, Spain
[4] Kings Coll London, Psychopharmacol Res Unit, London WC2R 2LS, England
来源
BEHAVIOURAL PHARMACOLOGY | 2004年 / 15卷 / 01期
关键词
rat; cannabinoid receptor agonist; 5-HT1A antagonist; plus-maze; holeboard;
D O I
10.1097/00008877-200402000-00003
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
We have studied the possible interaction between the cannabinoid receptor agonist CID 55,940 (1 and 50 mug/kg) and the 5-HT1A receptor antagonist WAY 100635 (11 mg/kg) in the modulation of plus-maze and holeboard activity in Wistar adult male rats. In the plus-maze, the higher dose of CID 55,940 induced an anxiogenic-like effect, whereas the lower dose induced anxiolytic-like responses. The 5-HT1A antagonist, which was silent in this test, attenuated the anxiogenic, but not the anxiolytic, effect of CID 55,940. In the holeboard, the higher dose of CP 55,940 significantly decreased head-dipping duration, and WAY 100635, which did not affect exploratory head-dipping when administered alone, antagonized this effect. The administration of WAY 100635 significantly increased grooming behaviour, and this effect was inhibited by the two doses of CP 55,940, which did not exert any effect, per se, on this parameter. We provide the first evidence implicating 5-HT1A receptors in anxiety-related behavioural responses to a cannabinoid agonist.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 50 条
  • [1] Aversive effects of the synthetic cannabinoid CP 55,940 in rats
    McGregor, IS
    Issakidis, CN
    Prior, G
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 53 (03) : 657 - 664
  • [2] Aversive Effects of the Kappa Opioid Agonist U-50488 Alone and in Combination with the Cannabinoid Agonist CP 55,940 in Male Rats
    Friend, Ashton
    Erwin, Laura
    Aslan, Abdurrahman
    Smith, William
    Nilges, Mark
    Winsauer, Peter
    FASEB JOURNAL, 2020, 34
  • [3] Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats
    Arnold, JC
    Hunt, GE
    McGregor, LS
    LIFE SCIENCES, 2001, 70 (01) : 97 - 108
  • [4] Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats
    Romero, EM
    Fernández, B
    Sagredo, O
    Gomez, N
    Urigüen, L
    Guaza, C
    De Miguel, R
    Ramos, JA
    Viveros, MP
    DEVELOPMENTAL BRAIN RESEARCH, 2002, 136 (02): : 85 - 92
  • [5] Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test
    Genn, RF
    Tucci, S
    Marco, EM
    Viveros, MP
    File, SE
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 77 (03) : 567 - 573
  • [6] Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats
    Marín, S
    Marco, E
    Biscaia, M
    Fernández, B
    Rubio, M
    Guaza, C
    Schmidhammer, H
    Viveros, MP
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 74 (03) : 649 - 656
  • [7] Anxiolytic and anxiogenic effects of the cannabinoid agonist CP 55,940 in animal tests of anxiety
    Genn, RF
    Tucci, S
    Marco, E
    Viveros, MP
    File, SE
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A27 - A27
  • [8] Effects of the cannabinoid receptor agonist CP-55,940 on incentive salience attribution
    Ali Gheidi
    Lora M. Cope
    Christopher J. Fitzpatrick
    Benjamin N. Froehlich
    Rachel Atkinson
    Coltrane K. Groves
    Clair N. Barcelo
    Jonathan D. Morrow
    Psychopharmacology, 2020, 237 : 2767 - 2776
  • [9] Effects of the cannabinoid receptor agonist CP-55,940 on incentive salience attribution
    Gheidi, Ali
    Cope, Lora M.
    Fitzpatrick, Christopher J.
    Froehlich, Benjamin N.
    Atkinson, Rachel
    Groves, Coltrane K.
    Barcelo, Clair N.
    Morrow, Jonathan D.
    PSYCHOPHARMACOLOGY, 2020, 237 (09) : 2767 - 2776
  • [10] Expedient synthesis of potent cannabinoid receptor agonist (-)-CP55,940
    Itagaki, N
    Sugahara, T
    Iwabuchi, Y
    ORGANIC LETTERS, 2005, 7 (19) : 4181 - 4183